Product Information
ZTLIDO 1.8% TOPICAL SYSTEM is a brand product labeled by Scilex Pharmaceuticals Inc., priced at $12.3074 per EA under NDC 69557011130. Its NADAC has been published 392 times since Feb 20, 2019.
FDA first approved this application on Feb 28, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lidocaine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
36 mg/1
Manufacturer
Scilex Pharmaceuticals Inc.NDC
69557011130
Classification
Brand
Dosage Form
PATCH
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
LIDOCAINEApproval Type
New Drug (NDA)
FDA Application
NDA207962FDA Approved
2/28/2018
TE Code
AB
On Market Since
4/26/2018
Pharmacological Classes
Price Statistics
The NADAC for ZTLIDO 1.8% TOPICAL SYSTEM has been published 392 times since Feb 20, 2019, and over the history we have for it it has risen 43.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3074 per EA |
|---|---|
| All-time high | $12.3221 (May 13, 2026) |
| All-time low | $8.6028 (Feb 20, 2019) |
| 52-week high | $12.3221 |
| 52-week low | $12.0016 |
| Median price | $9.7974 |
| Average price | $10.3764 |
| Largest weekly change | +9.8% (Feb 8, 2023) |
| Weeks tracked | 392 |
| Tracking since | Feb 20, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lidocaine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZTLIDO 1.8% TOPICAL SYSTEM?
The current National Average Drug Acquisition Cost (NADAC) for ZTLIDO 1.8% TOPICAL SYSTEM, manufactured by Scilex Pharmaceuticals Inc., is $12.3074 per EA (NDC 69557011130), effective Aug 19, 2026.
How has the price of ZTLIDO 1.8% TOPICAL SYSTEM changed over time?
Over the history we have for it, the NADAC for ZTLIDO 1.8% TOPICAL SYSTEM has risen 43.1%. It has been tracked across 392 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for ZTLIDO 1.8% TOPICAL SYSTEM?
Since Feb 20, 2019, the NADAC for ZTLIDO 1.8% TOPICAL SYSTEM has ranged from a low of $8.6028 (Feb 20, 2019) to a high of $12.3221 (May 13, 2026), with a median of $9.7974 per EA.
Are there cheaper alternatives to ZTLIDO 1.8% TOPICAL SYSTEM?
No other NADAC-published product currently shares the active ingredient and strength of ZTLIDO 1.8% TOPICAL SYSTEM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZTLIDO 1.8% TOPICAL SYSTEM?
ZTLIDO 1.8% TOPICAL SYSTEM (NDC 69557011130) is labeled by Scilex Pharmaceuticals Inc., and CMS classifies it as a brand product.